Veru enters at-the-market equity sales agreement with Oppenheimer, Canaccord

Veru Inc. disclosed in a Form 8-K that on July 2, 2026, it entered into a Sales Agreement with Oppenheimer & Co. Inc. and Canaccord Genuity LLC, acting as sales agents, allowing the company to issue and sell shares of its common stock from time to time through the agents.¹

The offering covers up to $21,800,000 of common stock, registered under a shelf registration statement that Veru filed on Form S-3 and that took effect on April 15, 2026, with the terms further detailed in a prospectus supplement filed with the SEC on the same day the sales agreement was signed.¹

Veru is under no requirement to actually issue stock under the arrangement. The Company is not obligated to sell any shares of Common Stock under the Sales Agreement.¹ Any sales that do occur will be handled at the agents' discretion within parameters set by Veru. Each sales agent will use commercially reasonable efforts to sell shares based on the company's instructions on price, timing, or size, structured as an "at the market offering" under Rule 415(a)(4) of the Securities Act.¹

On compensation terms, Veru will pay the designated sales agent a commission of 3.0% of gross proceeds from each sale, and has agreed to standard indemnification provisions covering liabilities under federal securities laws.¹ The company also agreed to reimburse the sales agents for certain specified expenses.¹

Supporting legal documentation was filed alongside the agreement. A legal opinion from Reinhart Boerner Van Deuren s.c., counsel to Veru, addressing the validity of shares to be issued under the agreement, was filed as an exhibit along with the related consent.¹ The filing was signed by Chief Financial Officer and Chief Administrative Officer Michele Greco.